This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: University of South Florida, Transgenex Nanobiotech Inc.. Active years: 2020-2025.
Company Filing History:
2 out of 1,986 
1 out of 6 Years Active: 2020-2025
Title: Mark Howell - Innovator in Cancer Treatment
Introduction
Mark Howell is a notable inventor based in Tampa, Florida, recognized for his contributions to cancer treatment. He holds a patent that addresses the critical issue of drug resistance in cancer therapies. His innovative approach aims to enhance the effectiveness of existing treatments and improve patient outcomes.
Latest Patents
Mark Howell's patent, titled "Methods and compositions for treating drug resistance in cancer," presents compositions and methods designed to combat cancer resistance to tyrosine kinase inhibitors. The patent outlines the administration of an anti-resistance agent, such as a CYP51A1 inhibitor or an agonist of miRNA-764, to patients. This method may be combined with the use of tyrosine kinase inhibitors to provide a comprehensive treatment strategy.
Career Highlights
Throughout his career, Mark Howell has worked with prominent organizations, including Transgenex Nanobiotech Inc. and the University of South Florida. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer treatment.
Collaborations
Mark Howell has collaborated with esteemed colleagues, including Subhra Mohapatra and Shyam S Mohapatra. These partnerships have contributed to the advancement of his research and the development of effective cancer treatment methods.
Conclusion
Mark Howell's work in developing methods to treat drug resistance in cancer showcases his dedication to improving healthcare outcomes. His innovative patent and collaborations highlight the importance of research in the fight against cancer.